MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'accenture'. Sat, 03 Sep 2011 02:41:18 +0100 http://www.medworm.com/index.php?rid=4179518&cid=t_203465_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F11%2Fguess-what-site-online-health-info.html The press release announcing Accenture's new "Consumer Survey: The Evolving Consumer and The Pharmaceutical Company Relationship" claims that the survey "suggests pharmaceutical companies are falling short in addressing this captive audience" (my emphasis; find the press release here).It's unfortunate that the press release uses "captive audience" to describe consumers who go online for health information. To a marketer, a captive audience is a technical term (jargon) that merely means "people who cannot avoid being exposed to an advertisement."The top line takeaway from the press release is that only "slightly more than one in 10 (11 percent) [of consumers who go online for health information] regularly turn to a pharmaceutical company’s website to seek information about an illness or m... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=4179518 Thu, 18 Nov 2010 13:15:00 +0100 4179518 http://www.medworm.com/index.php?rid=4172325&cid=t_203465_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fbbr6086Msv4%2F Not too many people do. At least that’s the finding of a recent survey, which found 66 percent of the respondents go online for health info, but only 11 percent regularly turn to a web site run by a drugmaker for info about an illness or medical condition. By comparison, 92 percent look at medical web sites, social media sites and online communities, such as chat rooms and forums, or a news or government site. Just the same, 69 percent of the 852 US adults who queried by Accenture’s Life Sciences sales and marketing practice expect drugmakers to provide info about a medical condition for which they are taking drugs. The suggestion is clear: pharma is failing to seize an opportunity while grappling with FDA regulations and the ins and outs of the Internet. While pharmaceutical ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4172325 Tue, 16 Nov 2010 19:19:11 +0100 4172325 http://www.medworm.com/index.php?rid=3933265&cid=t_203465_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FaKrQUrCNzEU%2F Good morning, everyone. How are you today? Slowing down just a bit, perhaps? Here in the states, of course, a three-day weekend is fast approaching. And so we will pull in the sidewalks early. We hope you have the opportunity to do the same. Meanwhile, here are a few nuggets to help you close out the week. Whatever you do over the next few days, may it be enjoyable. Cheers… Celldex Says Pfizer Ends Cancer Vaccine Deal (Reuters) Allergan Steps Up Overseas Clinical Trials (CBS News) Novartis Experimental Malaria Drug May Be First In 30 Years (Bloomberg News) Abbott Cancels Sale Of Solvay Vaccines Unit (The Wall Street Journal) Accenture And ICRI Partner On Indian Clinical Research Training (Outsourcing Pharma) (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3933265 Fri, 03 Sep 2010 12:02:08 +0100 3933265 http://www.medworm.com/index.php?rid=3460249&cid=t_203465_113_f&fid=34634&url=http%3A%2F%2Fwww.emrandhipaa.com%2Femr-and-hipaa%2F2010%2F04%2F01%2Fdiscussion-about-emr-study-by-accenture%2F Discussion of Obama EHR Stimulus Today the following videos came across my Twitter feed and... (Source: EMR and HIPAA) EMR and HIPAA blogs http://www.medworm.com/rss/comments.php?id=3460249 Thu, 01 Apr 2010 14:43:39 +0100 3460249 http://www.medworm.com/index.php?rid=1816187&cid=t_203465_122_f&fid=36582&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FSharpBrains%2F%7E3%2F399010221%2F A recent CNN article explains well why a growing number of companies use brainteasers and logic puzzles of a type called “guesstimations” during job interviews: - "Seemingly random questions like these have become commonplace in Silicon Valley and other tech outposts, where companies aren't as interested in the correct answer to a tough question as they are in how a prospective employee might try to solve it. Since businesses today have to be able to react quickly to shifting market dynamics, they want more than engineers with high IQs and good college transcripts. They want people who can think on their feet." What are technology companies (Google, Microsoft, Amazon) and consulting companies (McKinsey, Boston Consulting Group, Accenture...) looking for? They want employees w... SharpBrains blogs http://www.medworm.com/rss/comments.php?id=1816187 Sun, 21 Sep 2008 16:47:07 +0100 1816187